Lymphoproliferative disorders
Trial sponsors
Beijing Immunochina Medical Science & Technology
Company1 trialPhase 1/268 people
Nanjing NingQi Medicine Science and Technology
Company1 trialPhase 1/268 people
4 trialsPhase 2306 people
2 trialsPhase 2359 people
1 trialPhase 2204 people
1 trialPhase 255 people
Alliance for Clinical Trials in Oncology
1 trialPhase 26 people
Barbara Ann Karmanos Cancer Institute
1 trialPhase 24 people
Latest
Annual Review of Medicine
Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
ReviewMechanisms